摘要
目的对血液透析与血液灌流联合应用于血液透析患者肾性骨病的临床疗效进行观察探究。方法在我院2014年7月-2015年12月收治的血液透析肾性骨病患者90例,并随机均分为对照组和联合组。结果临床结果显示,联合组治疗有效率为95.56%,高于对照组的77.78%,两组治疗疗效差异经统计学检测,P〈0.05,差异有统计学意义;通过对患者治疗前后血钙、血i PTH及血磷的密切监测,两组均有所改善,同时联合组的血磷及血iPTH的下降优于对照组,所有差异均有统计学意义,P〈0.05。结论血液透析联合血液灌流应用于血液透析患者的肾性骨病治疗可以有效提高患者的治疗成功率,有效降低患者血磷及血iPTH值,对临床治疗具有显著意义。
Objective To hemodialysis associated with blood perfusion applied in hemodialysis patients of renal bone disease to explore the clinical curative effect observation. Methods 90 cases of hemodialysis renal bone disease patients were treated in our hospital from July 2014 to December 2015, and randomly divided into control group and combined group. Results Clinical results show that the combined treatment group effective rate was 95.56%, far higher than that of control group 77.78%, two groups of curative effect difference after statistics test, P〈0.05. In patients before and after treatment the blood calcium and blood i PTH and careful monitoring of blood phosphorus, two groups were improved, and the blood of the joint group phosphorus and reduced blood i PTH was better than control group, all differences P〈0.05, with statistical significance. Conclusion Hemodialysis union blood perfusion applied in hemodialysis patients with renal bone disease treatment can effectively improve the patient＇s sex treatment success, effectively reduce the patient＇s blood phosphorus and blood i PTH value, is significant for clinical treatment.
出处
《中国继续医学教育》
2016年第12期89-90,共2页
China Continuing Medical Education
关键词
血液透析
血液灌流
肾性骨病
Hemodialysis
Hemoperfusion
Renal osteodystrophy
